Skip to main content
logo
Bioextrax AB (publ) (STO:BIOEX)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.510
-0.030 (-1.18%)
Aug 12, 2026, 3:55 PM CET

Bioextrax AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-18.05-17.71-17.34-21.51-18.67-10.53
Depreciation & Amortization
1.11.131.160.860.480.35
Change in Receivables
3.35-10.04-3.561.51-0.73-2.06
Changes in Accounts Payable
0.360.580.96-4.171.323.76
Operating Cash Flow
-13.24-26.05-18.78-23.31-17.6-8.48
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--0.15-0.22-1.1-6.78-0.98
Purchases of Investments
-0.15-----
Investing Cash Flow
-0.2-0.15-0.22-1.1-6.78-0.98

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
12.8612.8622.8610.2842.9416.38
Net Common Stock Issued (Repurchased)
12.8612.8622.8610.2842.9416.38
Financing Cash Flow
12.8612.8622.8610.2842.9416.38

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-0.57-13.343.87-14.1318.566.93

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-13.24-26.2-18.99-24.41-24.38-9.45
Free Cash Flow Growth
------
FCF Margin
-983.51%-2001.38%-1878.64%-811.23%-1092.29%-915.00%
Free Cash Flow Per Share
-0.32-0.66-0.57-0.92-1.44-0.71
Levered Free Cash Flow
-16.59-16.16-15.44-25.92-23.65-7.4
Unlevered Free Cash Flow
-16.72-16.29-15.64-26.01-23.65-7.39